BUZZ-Australia's Telix Pharmaceuticals rises on China acceptance of new drug application

Reuters01-20 08:39
BUZZ-Australia's <a href="https://laohu8.com/S/TLX.AU">Telix Pharmaceuticals</a> rises on China acceptance of new drug application

** Shares of Australia's Telix Pharmaceuticals TLX.AX rise as much as 6.3% to A$11.99, posting their biggest intraday pct gain in nearly two months

** Stock touches its highest level since December-end

** Biopharma co says the Chinese National Medical Products Administration (NMPA) has accepted New Drug Application (NDA) for its prostate cancer diagnosis agent, Illuccix

** Says NDA submitted in association with partner Grand Pharmaceutical Group 0512.HK in Greater China region

** Illuccix used as a scanning agent to detect prostate cancer in body

** TLX among top gainers on the broader Australian benchmark index .AXJO, which is down 0.5%

** TLX up 4.6% YTD after a 54.5% drop in 2025

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment